Lu Alleruzzo, CEO and Robert Arch, SVP Corporate Development at Immunophotonics, Inc. are attending the MedInvest Biotech and Pharma Investor conference which will be held on March 27 – 28, in New York City.
Lu Alleruzzo and Robert Arch are presenting on March 27th at 12:25 pm. See how Immunophotonics is pioneering efforts that aim to prevent tumors from coming back and to allow cancer patients to lead healthy lives without the need for further therapies.
